20/160 | 1%† | |||||||
20/125 | 2%* | 1%* | 1%* | |||||
20/100 | 8% | 17% | 2% | 1% | 2% | 2% | 1% | |
20/80 | 16% | 17% | 4% | 4% | 2% | 2% | 2% | 5% |
20/63 | 32% | 31% | 12% | 11% | 6% | 8% | 5% | 7% |
20/50 | 27% | 19% | 27% | 15% | 17% | 7% | 7% | 8% |
20/40 | 18% | 17% | 20% | 24% | 24% | 19% | 21% | 10% |
20/32 | 21% | 33% | 27% | 31% | 33% | 27% | ||
20/25 | 11% | 11% | 13% | 21% | 15% | 22% | ||
20/20 | 4% | 9% | 9% | 13% | 14% | |||
20/16 | 1% | 5% | ||||||
Mean logMAR | 0.47 | 0.50 | 0.32 | 0.31 | 0.26 | 0.24 | 0.23 | 0.22 |
(SD) | 0.12 | 0.13 | 0.16 | 0.15 | 0.15 | 0.16 | 0.16 | 0.20 |
Mean Lines | -- | -- | 1.5 | 1.9 | 2.1 | 2.6 | 2.4 | 2.8 |
Change | ||||||||
(SD) | 1.3 | 1.3 | 1.2 | 1.5 | 1.4 | 1.8 | ||
Treatment Group | A | A + P | A | A + P | A | A + P | A | A + P |
Visit | Baseline | 5 Weeks | 10 Weeks | 18 Weeks |